Acting Chief von Eschenbach Brings Zeal For Imaging To FDA
This article was originally published in The Gray Sheet
Executive Summary
Andrew von Eschenbach's role in supporting the development of imaging and other diagnostic technology as director of the National Cancer Institute could inform his approach to medical device regulatory issues as he takes on the added role of acting FDA commissioner
You may also be interested in...
Von Eschenbach Clears Senate Handily After Months Of Debate
Andrew von Eschenbach can officially take the helm of FDA, following confirmation by the Senate Dec. 7
Von Eschenbach Clears Senate Handily After Months Of Debate
Andrew von Eschenbach can officially take the helm of FDA, following confirmation by the Senate Dec. 7
Von Eschenbach Is Likely Nominee For Permanent FDA Commissioner
FDA Acting Commissioner and National Cancer Institute Director Andrew von Eschenbach will likely be nominated by President George W. Bush as the permanent head of the agency, former FDA Associate Commissioner for External Relations Peter Pitts said March 9